{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:31:44Z","timestamp":1792531904824,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Microgravity"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite notable progress in realizing the benefits of microgravity, the physical stability of therapeutics processed in space has not been sufficiently investigated. Environmental factors including vibration, acceleration, radiation, and temperature, if not addressed, could impact the feasibility of in-space drug processing. The presented work demonstrates the successful recovery of the metastable Form III of ritonavir generated in orbit. The samples processed in orbit, along with control samples of Form I, Form II, Form III, and amorphous ritonavir brought to space and back exhibited excellent physical and chemical stability when exposed to space environments. Stability was determined through comparison to reference samples processed and held on Earth. By providing a detailed experimental dataset centered on survivability, we address a key concern in pharmaceutical processing under microgravity with potential applications for both drug development on Earth and pharmaceutical needs for long-duration human exploration initiatives.<\/jats:p>","DOI":"10.1038\/s41526-026-00594-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:05:10Z","timestamp":1775649910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A study on the stability of ritonavir form III processed in orbit and returned to Earth"],"prefix":"10.1038","volume":"12","author":[{"given":"Haley C.","family":"Bauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan. D.","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry R.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami S.","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Condon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McCalip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Croom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale K.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Bogdanowich-Knipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Cowans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Alajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Byrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Radocea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12217-019-09728-4","volume":"32","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Antisolvent crystallization of L-histidine in micro-channel reactor under microgravity. Microgravity Sci. Technol. 32, 27\u201333 (2020).","journal-title":"Microgravity Sci. Technol."},{"key":"594_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11095-019-2703-7","volume":"36","author":"S Amselem","year":"2019","unstructured":"Amselem, S. Remote controlled autonomous microgravity lab platforms for drug research in space. Pharm. Res. 36, 183 (2019).","journal-title":"Pharm. Res."},{"key":"594_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-019-2719-z","volume":"37","author":"MA Giulianotti","year":"2020","unstructured":"Giulianotti, M. A. & Low, L. A. Pharmaceutical research enabled through microgravity: Perspectives on the use of the International Space Station U.S. Natl. Lab. Pharm. Res. 37, 1 (2020).","journal-title":"Natl. Lab. Pharm. Res."},{"key":"594_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41526-019-0090-3","volume":"5","author":"P Reichert","year":"2019","unstructured":"Reichert, P. et al. Pembrolizumab microgravity crystallization experimentation. npj Microgravity 5, A28 (2019).","journal-title":"npj Microgravity"},{"key":"594_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/cryst15060527","volume":"15","author":"L Miller","year":"2025","unstructured":"Miller, L. et al. Crystallization of small molecules in microgravity using pharmaceutical in-space laboratory-biocrystal optimization eXperiment (PIL-BOX). Crystals 15, 527 (2025).","journal-title":"Crystals"},{"key":"594_CR6","unstructured":"Byrn, S. R., Pfeiffer, R. R. & Stowell, J. G. Solid-State Chemistry of Drugs (SSCI, Inc., 1999)."},{"key":"594_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1023\/A:1011052932607","volume":"18","author":"J Bauer","year":"2001","unstructured":"Bauer, J. et al. Ritonavir: an extraordinary example of conformational polymorphism. Pharm. Res. 18, 859\u2013866 (2001).","journal-title":"Pharm. Res."},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"18759","DOI":"10.3390\/molecules201018759","volume":"10","author":"R Censi","year":"2015","unstructured":"Censi, R. & Martino, P. D. Polymorph impact on the bioavailability and stability of poorly soluble drugs. Molecules 10, 18759\u201318776 (2015).","journal-title":"Molecules"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"17479","DOI":"10.1021\/jacs.1c06837","volume":"143","author":"AY Sheikh","year":"2021","unstructured":"Sheikh, A. Y. Implications of the conformationally flexible, macrocyclic structure of the first-generation, direct-acting anti-viral paritaprevir on its solid form complexity and chameleonic behavior. J. Am. Chem. Soc. 143, 17479\u201317491 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"594_CR10","doi-asserted-by":"crossref","unstructured":"Williams, P. M., Shivakumar, T. & Anyanwu, V. Space medicine and countermeasures. In In-Space Manufacturing and Resources (Wiley Online Books, 2022).","DOI":"10.1002\/9783527830909.ch2"},{"key":"594_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41526-023-00271-6","volume":"9","author":"JF Reichard","year":"2023","unstructured":"Reichard, J. F. et al. The effect of long-term spaceflight on drug potency and the risk of medication failure. npj Microgravity 9, A35 (2023).","journal-title":"npj Microgravity"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1208\/s12248-015-9834-5","volume":"18","author":"VE Wotring","year":"2016","unstructured":"Wotring, V. E. Chemical potency and degradation products of medications stored over 550 Earth Days at the International Space Station. AAPS J. 18, 210\u2013216 (2016).","journal-title":"AAPS J."},{"key":"594_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1208\/s12248-011-9270-0","volume":"13","author":"B Du","year":"2011","unstructured":"Du, B. et al. Evaluation of physical and chemical changes in pharmaceuticals flow on space missions. AAPS J. 13, 299\u2013308 (2011).","journal-title":"AAPS J."},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/jps.10271","volume":"92","author":"L Maggi","year":"2003","unstructured":"Maggi, L. et al. Chemical and physical stability of hydroxypropyl methylcellulose matrices containing diltiazem hydrochloride after gamma irradiation. J. Pharm. Sci. 92, 131\u2013141 (2003).","journal-title":"J. Pharm. Sci."},{"key":"594_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41526-025-00469-w","volume":"11","author":"I Plant","year":"2025","unstructured":"Plant, I. et al. The long-term stability of solid-state oral pharmaceuticals exposed to simulated intravehicular space radiation. npj Microgravity 11, 17 (2025).","journal-title":"npj Microgravity"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1126\/science.adk8216","volume":"381","author":"M Gresko","year":"2023","unstructured":"Gresko, M. Panel calls for giant boost to space station research. Science 381, 1144\u20131145 (2023).","journal-title":"Science"},{"key":"594_CR17","unstructured":"Foust, J. NASA hits limits of Space Station Utilization Space News (January 31, 2023)."},{"key":"594_CR18","unstructured":"Foust, J. SpaceX Revamps Smallsat Rideshare Program Space News (August 29, 2019)."},{"key":"594_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1021\/acs.cgd.2c01017","volume":"23","author":"SD Parent","year":"2022","unstructured":"Parent, S. D. et al. Ritonavir form III: a coincidental concurrent discovery Crystal. Growth Des. 23, 320\u2013325 (2022).","journal-title":"Growth Des."},{"key":"594_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.xphs.2022.09.026","volume":"112","author":"X Yao","year":"2022","unstructured":"Yao, X., Henry, R. F. & Zhang, G. G. Z. Ritonavir Form III: a new polymorph after 24 years. J. Pharm. Sci. 112, 237\u2013242 (2022).","journal-title":"J. Pharm. Sci."},{"key":"594_CR21","unstructured":"Space Exploration Technologies Corp. Rideshare Payload User\u2019s Guide (SpaceX, 2021). Available at https:\/\/www.spacex.com\/rideshare (accessed 15 Mar 2024)."},{"key":"594_CR22","doi-asserted-by":"crossref","unstructured":"Finke, R. G. Calculation of reentry-vehicle temperature history Institute for Defense Analysis IDA Paper P-2395 (1990).","DOI":"10.21236\/ADA231552"},{"key":"594_CR23","doi-asserted-by":"crossref","unstructured":"Mohr, M. & Fecht, H. Investigating thermophysical properties under microgravity: a review. Adv. Eng. Mater. 23, 2001223 (2021).","DOI":"10.1002\/adem.202170006"},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/jps.22197","volume":"99","author":"JA Baird","year":"2010","unstructured":"Baird, J. A., Van Eerdenbrugh, B. & Taylor, L. S. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J. Pharm. Sci. 99, 3787\u20133806 (2010).","journal-title":"J. Pharm. Sci."},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1021\/cg070292g","volume":"8","author":"PWG Poodt","year":"2008","unstructured":"Poodt, P. W. G., Christianen, P. C. M., van Enckevort, W. J. P., Maan, J. C. & Vlieg, E. The critical Rayleigh number in low gravity crystal growth from solution. Cryst. Growth Design 8, 2194\u20132199 (2008).","journal-title":"Cryst. Growth Design"},{"key":"594_CR26","doi-asserted-by":"crossref","unstructured":"Snell, E. H. & Helliwell, J. R. Macromolecular crystallization in microgravity. Rep. Progress Phys. 68, 799 (2005).","DOI":"10.1088\/0034-4885\/68\/4\/R02"},{"key":"594_CR27","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1021\/acs.cgd.3c01274","volume":"24","author":"K Pal","year":"2024","unstructured":"Pal, K. & Radocea, A. Gravity as a knob for tuning particle size distributions of small molecules. Cryst. Growth Design 24, 2370\u20132383 (2024).","journal-title":"Cryst. Growth Design"},{"key":"594_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jpba.2008.08.007","volume":"48","author":"RS Yekkala","year":"2008","unstructured":"Yekkala, R. S. et al. Evaluation of an International Pharmacopoeia method for the analysis of ritonavir by liquid chromatography. J. Pharm. Biomed. Anal. 48, 1050\u20131054 (2008).","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["npj Microgravity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41526-026-00594-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41526-026-00594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41526-026-00594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:02:33Z","timestamp":1781089353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41526-026-00594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1038\/s41526-026-00594-0","relation":{},"ISSN":["2373-8065"],"issn-type":[{"value":"2373-8065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interest(s): Varda Space Industries participated in the experimental design, research, data interpretation and analysis, writing, reviewing, and approval of the publication. H.C. Bauser, A.S. Bhavsar, A. McCalip, L.R. Chan, K. H. Condon, J.M. Croom, and A. Radocea are employees of Varda Space Industries and may own Varda Space Industries stock.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}